SMN1 and proximal spinal muscular atrophy: Significant progress has been made recently for SMA treatment with the approval of three drugs, Spinraza (Nursinersen), Risdiplam (Evrysdi), and Onasemnogene Abeparvovec (Zolgensma), that are able to increase the level of SMN protein.